SARS-CoV-2 vaccines: fast track versus efficacy
2021 · The Lancet Microbe · 25 citations
https://doi.org/10.1016/s2666-5247(21)00034-3
D
Dana Alkandari
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Dana Alkandari is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat